This medication requires a valid prescription. Please refer to the ‘Prescription Guide’ for details.
Note: We can assist only if the medicine is unavailable in your country.”
Onivyde (irinotecan hydrochloride trihydrate)
General Description:
Onivyde (irinotecan hydrochloride trihydrate) is an intravenous chemotherapy used in the treatment of pancreatic cancer. It works by interfering with DNA replication in cancer cells, slowing tumor growth and improving patient outcomes.
Onivyde is administered under the supervision of a qualified oncologist in a clinical setting. Dosage and treatment schedules are personalized based on patient condition and response.
Getting Onivyde (irinotecan hydrochloride trihydrate) in India
Onivyde is approved by multiple international regulatory authorities, including the FDA (U.S.), EMA (Europe), Health Canada, TGA (Australia), and Medsafe (New Zealand). While not yet widely available in India, patients may access it legally through a Named Patient Program (NPP) under the guidance of a licensed physician.
MitoGENE supports Indian patients in obtaining Onivyde safely and efficiently, coordinating all regulatory paperwork, import permits, and logistics for a transparent process.
Medicine Approved By:
• Food and Drug Administration (FDA)
• European Medicines Agency (EMA)
• Health Canada
• Therapeutic Goods Administration (TGA)
• Medsafe (NZ)
Available Dosage Form & Package:
• Single vial: 43 mg (4.3 mg/10 mL) solution
Disease Indication:
• Pancreatic Cancer
Manufacturer:
Baxalta Innovations GmbH
Usage:
Intravenous
Shipping:
Cold Chain Shipping
Odomzo requires cold chain shipping to protect it from heat, light, and handling. Specialized medical couriers use temperature-controlled packaging and vehicles to maintain optimal conditions, ensuring the medication remains effective and safe during transit.
How to Access Onivyde (irinotecan hydrochloride trihydrate) in India in 4 Simple Steps with MitoGENE via the Named Patient Program (NPP)?
If Onivyde (irinotecan hydrochloride trihydrate) is not yet approved or commercially available in India, MitoGENE can assist you in accessing it legally through the Named Patient Program (NPP). Here’s how the process works:
